The American Association of Clinical Endocrinologists and American College of Endocrinology have released their 2016 outpatient glucose monitoring consensus statement.

Among the recommendations:

• The authors suggest continuous glucose monitoring (CGM) for people with type 1 diabetes with a history of severe hypoglycemia or hypoglycemia unawareness, as well as for patients not at goal based on A1C.

• Many pediatric patients with type 1 diabetes are candidates for CGM, especially if they and their family caregivers have the appropriate training.

• Meaningful monitoring in patients with type 2 diabetes should be individualized depending on the risk of hypoglycemia estimated based on prior history, presence of hypoglycemia unawareness, and the nature of the current therapy.

• More trials are needed to identify the settings in which CGM in type 2 diabetes can be most beneficial and cost-effective.

• Patients and clinicians should be educated to understand and use glucose monitoring data.

Citation: Bailey T, Grunberger G, Bode B, et al. American Association of Clinical Endocrinologists and American College of Endocrinology 2016 outpatient glucose monitoring consensus statement. Endocr Pract. 2016;22(2):231-261. doi: 10.4158/EP151124.CS.